A

aPCC

Activated prothrombin complex concentrate (aPCC) is a scientific term for the bypassing therapy FEIBA®. 1

B

Bypassing agent

A type of treatment developed for people with inhibitors; bypassing treatments go around (or bypass) the factors that are blocked by the inhibitor to help the body form a normal clot. 2,3

F

Factor replacement therapy

A treatment that replaces the low or missing factor in people with hemophilia so that blood will clot if you have an injury. 3

I

Intravenous

A method to deliver medicine into the body that involves inserting a needle directly into the vein. 4

P

Pharmacokinetics

The movement of a drug into, through, and out of the body. 5

Prophylactic

The regular use of a medicine to prevent something from occurring. In hemophilia, prophylaxis is intended to prevent or reduce bleeding. 6,7

 

S

Subcutaneous

A method to deliver medicine into the body that involves inserting a needle into the fatty tissue just beneath the skin. 4

 

T

Therapeutic antibody

Therapeutic antibodies, often referred to as monoclonal antibodies, are designed to have the same ability as natural antibodies to bind to specific molecules. They are laboratory-produced molecules that are designed to recognize and attach to specific proteins to help treat a disease. 8

Treated bleed

A bleed that requires treatment as determined by the individual or their healthcare provider. 9